Health ❯Clinical Trials

Phase 3 Trials

AFFINE Trial Pelabresib Trial Patient Studies ACHIEVE-1 Trial Vaccine Efficacy

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

Moderna plans to roll out the shot ahead of the 2025–26 respiratory season

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

Pfizer Ends Hemophilia Gene Therapy Partnership With Sangamo, Sending Stock Plummeting

Novartis Acquires MorphoSys for $2.9 Billion, Expanding Cancer Drug Portfolio